Effect of targeted drug treatment for nasopharyngeal carcinoma

Many nasopharyngeal cancer patients are suffering from the pain brought by nasopharyngeal cancer. After suffering from nasopharyngeal cancer, how to treat it has become a very concerned issue for most nasopharyngeal cancer patients. Among them, targeted therapy is a better way to treat tumors in recent years, especially targeted therapy for nasopharyngeal cancer has achieved excellent results. Although targeted therapy for nasopharyngeal cancer is no longer news, there are still not many people who really know about targeted therapy for nasopharyngeal cancer.

Effect of targeted drug treatment on nasopharyngeal carcinoma

We probably don't know much about targeted therapy. Targeted therapy is a type of therapy that can inhibit the occurrence and development of tumors or eliminate tumors through various mechanisms. So what is the effect of targeted therapy for nasopharyngeal carcinoma? With the continuous improvement of medical standards, there are more and more ways to treat nasopharyngeal carcinoma, including: radiotherapy, surgical treatment, chemotherapy, immunotherapy and traditional Chinese medicine treatment. Radiotherapy is the first choice in clinical practice. Taixinsheng (Nimotuzumab) is a targeted drug for the treatment of nasopharyngeal carcinoma, and it is also the only targeted drug for the treatment of nasopharyngeal carcinoma in the world. It is the first autologous monoclonal antibody officially launched in China. Taixinsheng can significantly inhibit tumor cell proliferation, induce decomposition, promote cell apoptosis, inhibit tumor angiogenesis, and enhance the effect of radiotherapy and chemotherapy. The drug has strong targeting and low toxicity and side effects, representing the latest development direction in the field of tumor molecular targeted therapy.

Clinical research results show that Taixinsheng is a targeted drug for the treatment of nasopharyngeal carcinoma with good tolerance and can increase the radiotherapy sensitivity of tumors. The biggest feature is that while killing tumor cells, it has very little effect on normal cells, and the patient's tolerance and quality of life are improved. Taixinsheng combined with radiotherapy further improves the patient's effect and survival rate without significantly increasing toxicity. Clinically, it is used in combination with radiotherapy to achieve better results than radiotherapy alone and prolong the median survival time. Data from a clinical study on targeted treatment of nasopharyngeal carcinoma conducted in China showed that the effectiveness of Taixinsheng combined with radiotherapy was 100%; and the complete remission rate of tumors was 90.63%;. The results of the 3-year survival period follow-up showed that compared with radiotherapy alone, the 3-year survival rate of the Taixinsheng combined with radiotherapy group was 84.29%;, which was 7 percentage points higher than the control group, significantly prolonging the patient's survival time, and the toxic and side effects were not significantly different from those of radiotherapy alone, providing a new treatment method for patients with advanced nasopharyngeal carcinoma, which is worthy of clinical promotion and application.